MIDODRINE


Synonyms	Midodrine ST 1085 ST-1085
Status
Molecule Category	Free-form
ATC	C01CA17
UNII	6YE7PBM15H
EPA CompTox	DTXSID0023321


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	PTKSEFOSCHHMPD-UHFFFAOYSA-N
Smiles	COc1ccc(OC)c(C(O)CNC(=O)CN)c1
InChI	InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C12H18N2O4
Molecular Weight	254.29
AlogP	-0.19
Hydrogen Bond Acceptor	5.0
Hydrogen Bond Donor	3.0
Number of Rotational Bond	6.0
Polar Surface Area	93.81
Molecular species	NEUTRAL
Aromatic Rings	1.0
Heavy Atoms	18.0

Related Entries

Cross References

Resources	Reference
ChEBI	6933
ChEMBL	CHEMBL1201212
DrugBank	DB00211
DrugCentral	1803
FDA SRS	6YE7PBM15H
Human Metabolome Database	HMDB0014356
Guide to Pharmacology	7240
KEGG	C07890
PharmGKB	PA164749381
PubChem	4195
SureChEMBL	SCHEMBL131436

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).